CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death

Open access

Abstract

We previously synthesized new 5-thienyl-substituted 2-aminobenzamide-type HDAC1, 2 inhibitors with the (4-ethyl-2,3-dioxopiperazine-1-carboxamido) methyl group. K-560 (1a) protected against neuronal cell death in a Parkinson’s disease model by up-regulating the expression of XIAP. This finding prompted us to design new K-560-related compounds. We examined the structure activity relationship (SAR) for the neuronal protective effects of newly synthesized and known K-560 derivatives after cerebral ischemia. Among them, K-856 (8), containing the (4-methyl-2,5-dioxopiperazin-1-yl) methyl group, exhibited a promising neuronal survival activity. The SAR study strongly suggested that the attachment of a monocyclic 2,3- or 2,5-diketopiperazine group to the 2-amino-5-aryl (but not 2-nitro-5-aryl) scaffold is necessary for K-560-related compounds to exert a potent neuroprotective effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-19664-9

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structures of Known K560-Derivatives and Synthetic Routes of New K-560-Related Compounds 3, 4 and 5. Reagents and Conditions: (a) Pd(PPh3)4, phenylboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (b) Pd(PPh3)4, 3-furanboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (c) Pd(PPh3)4, 2-furanboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (d) p-(chloromethyl) benzoyl chloride, Et3N or Py, THF; (e) potassium phthalimide, KI, DMF; (f) NH2NH2·H2O, EtOH; (g) 4-ethyl-2,3-dioxo-1-piperazinecarbonyl chloride, Et3N, CH2Cl2; (h) TFA, CH2Cl2, then NaHCO3.
Figure 1 Structures of Known K560-Derivatives and Synthetic Routes of New K-560-Related Compounds 3, 4 and 5. Reagents and Conditions: (a) Pd(PPh3)4, phenylboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (b) Pd(PPh3)4, 3-furanboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (c) Pd(PPh3)4, 2-furanboronic acid, K2CO3, P(o-MeC6H4)3, DME, H2O; (d) p-(chloromethyl) benzoyl chloride, Et3N or Py, THF; (e) potassium phthalimide, KI, DMF; (f) NH2NH2·H2O, EtOH; (g) 4-ethyl-2,3-dioxo-1-piperazinecarbonyl chloride, Et3N, CH2Cl2; (h) TFA, CH2Cl2, then NaHCO3.CC BY · PubMed Central
Figure 2 Synthetic Routes of New K-560-Related Compounds 6, 7, 8, 9, 10 and 11. Reagents and conditions: (a) 4-ethyl-2,3-dioxo-1-piperazine, NaH, DMF; (b) cyclo-L-prolylglycine, NaH, DMF; (c) 1-methylpiperazine-2,5-dione, NaH, DMF; (d) 1-methyl-piperazin-2-one, NaH, THF; (e) tert-butyl 3-oxopiperazine-1-carboxylate, NaH, THF; (f) 1-ethylpiperazine, NaH, THF; (g) TFA, CH2Cl2, then NaHCO3.
Figure 2 Synthetic Routes of New K-560-Related Compounds 6, 7, 8, 9, 10 and 11. Reagents and conditions: (a) 4-ethyl-2,3-dioxo-1-piperazine, NaH, DMF; (b) cyclo-L-prolylglycine, NaH, DMF; (c) 1-methylpiperazine-2,5-dione, NaH, DMF; (d) 1-methyl-piperazin-2-one, NaH, THF; (e) tert-butyl 3-oxopiperazine-1-carboxylate, NaH, THF; (f) 1-ethylpiperazine, NaH, THF; (g) TFA, CH2Cl2, then NaHCO3.CC BY · PubMed Central
Figure 3 Evaluation of Percentages of Cell Death in Primary Cultures of Rat Cortical Neurons Exposed to HDAC Inhibitors. Cell death (%) in primary cultures of rat cortical neurons was determined by measuring LDH release 24 h or 48 h after OGD. Cultures were incubated with (A) 1a, 3, 4 or 5 each at 1 μM; (B) 6, 7, 8 or 1a each at 1 μM; (C) 8 or 1a each at 1 μM; (D) 1b, 2a or 2b each at 1 μM, under the conditions noted in the section of Materials and Methods. Each value is the mean ± standard error mean of triplicate measurements. The asterisk denotes a significant difference (*p < 0.05) versus the control (0.1% DMSO).
Figure 3 Evaluation of Percentages of Cell Death in Primary Cultures of Rat Cortical Neurons Exposed to HDAC Inhibitors. Cell death (%) in primary cultures of rat cortical neurons was determined by measuring LDH release 24 h or 48 h after OGD. Cultures were incubated with (A) 1a, 3, 4 or 5 each at 1 μM; (B) 6, 7, 8 or 1a each at 1 μM; (C) 8 or 1a each at 1 μM; (D) 1b, 2a or 2b each at 1 μM, under the conditions noted in the section of Materials and Methods. Each value is the mean ± standard error mean of triplicate measurements. The asterisk denotes a significant difference (*p < 0.05) versus the control (0.1% DMSO).CC BY · PubMed Central
Figure 4 Dose-Dependent Evaluation of Percentages of Cell Death in Primary Cultures of Rat Cortical Neurons Exposed to HDAC Inhibitors. Cell death (%) in primary cultures of rat cortical neurons was determined by measuring LDH release 48 h after OGD. Cultures were incubated with (A) 8 or 1a each at 0.1, 0.3, 1, 3 or 10 μM; (B) FK228 (at 0.1, 1 or 10 μM), MS-275 (at 0.3, 1, 10 μM), 1a (at 0.3 μM) and 8 (at 3 μM); (C) 9, 10, 11 (each at 1, 3 or 10 μM), 1a (at 0.3 μM) and 8 (at 3 μM), under the conditions noted in the section of Materials and Methods. Each value is the mean ± standard error mean of triplicate measurements. The asterisk denotes a significant difference (*p < 0.05) versus the control (0.1% DMSO).
Figure 4 Dose-Dependent Evaluation of Percentages of Cell Death in Primary Cultures of Rat Cortical Neurons Exposed to HDAC Inhibitors. Cell death (%) in primary cultures of rat cortical neurons was determined by measuring LDH release 48 h after OGD. Cultures were incubated with (A) 8 or 1a each at 0.1, 0.3, 1, 3 or 10 μM; (B) FK228 (at 0.1, 1 or 10 μM), MS-275 (at 0.3, 1, 10 μM), 1a (at 0.3 μM) and 8 (at 3 μM); (C) 9, 10, 11 (each at 1, 3 or 10 μM), 1a (at 0.3 μM) and 8 (at 3 μM), under the conditions noted in the section of Materials and Methods. Each value is the mean ± standard error mean of triplicate measurements. The asterisk denotes a significant difference (*p < 0.05) versus the control (0.1% DMSO).CC BY · PubMed Central
Figure 5 Assessment of Toxicity Degree of HDAC inhibitors for SH-SY5Y Cells by Flow Cytometry. SH-SY5Y cells were treated with 1a, 3, 4, 5, 6, 8, 9, 10 or 11 for 48 h as indicated in the section of Material and Methods, and their DNA contents were analyzed using flow cytometry. The percentages of the population in the Sub-G0/G1, G0/G1, S and G2/M phase are indicated. 0.1%DMSO was used as a control. The experiment was repeated three times and representative histograms are shown.
Figure 5 Assessment of Toxicity Degree of HDAC inhibitors for SH-SY5Y Cells by Flow Cytometry. SH-SY5Y cells were treated with 1a, 3, 4, 5, 6, 8, 9, 10 or 11 for 48 h as indicated in the section of Material and Methods, and their DNA contents were analyzed using flow cytometry. The percentages of the population in the Sub-G0/G1, G0/G1, S and G2/M phase are indicated. 0.1%DMSO was used as a control. The experiment was repeated three times and representative histograms are shown.CC BY · PubMed Central
Figure 6 Structural Regions of 5-Thienyl-Substituted 2-Aminobenzamide type HDAC Inhibitors.
Figure 6 Structural Regions of 5-Thienyl-Substituted 2-Aminobenzamide type HDAC Inhibitors.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. Uesato, S. & Hirata, Y. Proceedings of Frontiers in Medicinal Chemistry (FMC), P172, Antwerp, Belgium September 14–16 (2015).

Cited by

See all 21

Metadata

Authors
Hirata, Y., Sasaki, T., Kanki, H., Choong, C.-J., Nishiyama, K., Kubo, G., Hotei, A., Taniguchi, M., Mochizuki, H., & Uesato, S.
Affiliations
  • Kansai University (JP)
  • The University of Osaka (JP)
  • Osaka University of Pharmaceutical Sciences (JP)
Corresponding author
  • Sasaki, Tsutomu
  • Uesato, Shinichi
Venue
Scientific Reports
Published
2018-01-23
Volume
8
Issue
1
Pages
1400-1400
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2807656347
Cited by
20
References
50
Citations by year
2024: 1 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 2
FWCI
0.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Smoking Research Foundation
  • Japan Society for the Promotion of Science (16K15317, 17F17413, 17H05700)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
histone deacetylase inhibitors, diketopiperazines, cerebral ischemia, neuronal cell death, neuroprotection, XIAP, Parkinson's disease model, structure-activity relationship
MeSH terms
Animals, Benzamides, Cell Line, Brain Ischemia, Humans, Models, Biological, Neurons, Structure-Activity Relationship, Molecular Structure, Cell Death, Neuroprotective Agents, Rats, Diketopiperazines, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death. https://app.cochat.ai/papers/10.1038/s41598-018-19664-9
The paper
Hirata, Y., Sasaki, T., Kanki, H., Choong, C.-J., Nishiyama, K., Kubo, G., Hotei, A., Taniguchi, M., Mochizuki, H., & Uesato, S. (2018). New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death. Scientific Reports. https://doi.org/10.1038/s41598-018-19664-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.